Código QR (código de barras bidimensional)

Daunorubicin and Its Active Metabolite Pharmacokinetic Profiles in Acute Myeloid Leukaemia Patients: A Pharmacokinetic Ancillary Study of the BIG-1 Trial

Daunorubicin pharmacokinetics (PK) are characterised by an important inter-individual variability, which raises questions about the optimal dose regimen in patients with acute myeloid leukaemia. The aim of the study is to assess the joint daunorubicin/daunorubicinol PK profile and to define an optim...

Fuld beskrivelse

Na minha lista:
Principais autores: Guillaume Drevin, Marie Briet, Caroline Bazzoli, Emmanuel Gyan, Aline Schmidt, Hervé Dombret, Corentin Orvain, Aurelien Giltat, Christian Recher, Norbert Ifrah, Philippe Guardiola, Mathilde Hunault-Berger, Chadi Abbara
Format: Artigo
Sprog:Inglês
Udgivet: MDPI AG 2022-04-01
Serier:Pharmaceutics
Fag:
daunorubicin
pharmacokinetics
acute myeloid leukaemia
modelling
Online adgang:https://www.mdpi.com/1999-4923/14/4/792
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker